EdgarLookup

Piedmont Realty Trust, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Piedmont Realty Trust, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-14.8%
Profit Margin
Net income ÷ revenue
-2.1%
Return on Assets
Net income ÷ assets
1.7x
Debt-to-Equity
Total liabilities ÷ equity
-0.9%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $564.99M Feb 17, 2026
FY2025 Dec 31, 2024 $570.32M Feb 17, 2026
FY2025 Dec 31, 2023 $577.76M Feb 17, 2026
FY2024 Dec 31, 2022 $563.77M Feb 19, 2025
FY2023 Dec 31, 2021 $528.71M Feb 20, 2024
FY2020 Dec 31, 2020 $131.53M Feb 17, 2021
FY2020 Sep 30, 2020 $131.69M Feb 17, 2021
FY2020 Jun 30, 2020 $134.63M Feb 17, 2021
FY2020 Mar 31, 2020 $137.17M Feb 17, 2021
FY2020 Dec 31, 2019 $134.15M Feb 17, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($83.62M) Feb 17, 2026
FY2025 Dec 31, 2024 ($79.07M) Feb 17, 2026
FY2025 Dec 31, 2023 ($48.39M) Feb 17, 2026
FY2024 Dec 31, 2022 $146.83M Feb 19, 2025
FY2023 Dec 31, 2021 ($1.15M) Feb 20, 2024
FY2020 Dec 31, 2020 $22.61M Feb 17, 2021
FY2020 Sep 30, 2020 $8.94M Feb 17, 2021
FY2020 Jun 30, 2020 $192.43M Feb 17, 2021
FY2020 Mar 31, 2020 $8.71M Feb 17, 2021
FY2020 Dec 31, 2019 $162.48M Feb 17, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $115.67M Feb 20, 2019
FY2017 Dec 31, 2017 ($16.25M) Feb 21, 2018
FY2017 Sep 30, 2017 $28.76M Feb 21, 2018
FY2017 Jun 30, 2017 $35.49M Feb 21, 2018
FY2017 Mar 31, 2017 $33.30M Feb 21, 2018
FY2017 Dec 31, 2016 $26.63M Feb 21, 2018
FY2017 Sep 30, 2016 $2.99M Feb 21, 2018
FY2017 Jun 30, 2016 $14.79M Feb 21, 2018
FY2017 Mar 31, 2016 $26.37M Feb 21, 2018
FY2016 Dec 31, 2015 $28.94M May 8, 2017

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $140.57M Feb 17, 2026
FY2025 Dec 31, 2024 $198.11M Feb 17, 2026
FY2025 Dec 31, 2023 $210.13M Feb 17, 2026
FY2024 Dec 31, 2022 $215.22M Feb 19, 2025
FY2023 Dec 31, 2021 $242.20M Feb 20, 2024
FY2022 Dec 31, 2020 $193.28M Feb 23, 2023
FY2021 Dec 31, 2019 $208.48M Feb 17, 2022
FY2020 Dec 31, 2018 $202.87M Feb 17, 2021
FY2019 Dec 31, 2017 $242.81M Feb 19, 2020
FY2018 Dec 31, 2016 $231.85M Feb 20, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.03B Feb 17, 2026
FY2025 Dec 31, 2024 $4.11B Feb 17, 2026
FY2024 Dec 31, 2023 $4.06B Feb 19, 2025
FY2023 Dec 31, 2022 $4.09B Feb 20, 2024
FY2022 Dec 31, 2021 $3.93B Feb 23, 2023
FY2021 Dec 31, 2020 $3.74B Feb 17, 2022
FY2020 Dec 31, 2019 $3.52B Feb 17, 2021
FY2019 Dec 31, 2018 $3.59B Feb 19, 2020
FY2018 Dec 31, 2017 $4.00B Feb 20, 2019
FY2017 Dec 31, 2016 $4.37B Feb 21, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.53B Feb 17, 2026
FY2025 Dec 31, 2024 $2.53B Feb 17, 2026
FY2024 Dec 31, 2023 $2.33B Feb 19, 2025
FY2023 Dec 31, 2022 $2.24B Feb 20, 2024
FY2022 Dec 31, 2021 $2.14B Feb 23, 2023
FY2021 Dec 31, 2020 $1.84B Feb 17, 2022
FY2020 Dec 31, 2019 $1.70B Feb 17, 2021
FY2019 Dec 31, 2018 $1.88B Feb 19, 2020
FY2018 Dec 31, 2017 $2.01B Feb 20, 2019
FY2017 Dec 31, 2016 $2.27B Feb 21, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.50B Feb 17, 2026
FY2025 Dec 31, 2024 $1.59B Feb 17, 2026
FY2024 Dec 31, 2023 $1.72B Feb 19, 2025
FY2023 Dec 31, 2022 $1.85B Feb 20, 2024
FY2022 Dec 31, 2021 $1.79B Feb 23, 2023
FY2021 Dec 31, 2020 $1.90B Feb 17, 2022
FY2020 Dec 31, 2019 $1.82B Feb 17, 2021
FY2019 Dec 31, 2018 $1.71B Feb 19, 2020
FY2018 Dec 31, 2017 $1.98B Feb 20, 2019
FY2017 Dec 31, 2016 $2.10B Feb 21, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $53.49M Feb 17, 2026
FY2025 Dec 31, 2024 $53.49M Feb 17, 2026
FY2025 Dec 31, 2023 $53.49M Feb 17, 2026
FY2023 Dec 31, 2022 $82.94M Feb 20, 2024
FY2022 Dec 31, 2021 $98.92M Feb 23, 2023
FY2021 Dec 31, 2020 $98.92M Feb 17, 2022
FY2020 Dec 31, 2019 $98.92M Feb 17, 2021
FY2019 Dec 31, 2018 $98.92M Feb 19, 2020
FY2018 Dec 31, 2017 $98.92M Feb 20, 2019
FY2017 Dec 31, 2016 $98.92M Feb 21, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $731.0K Feb 17, 2026
FY2025 Dec 31, 2024 $109.64M Feb 17, 2026
FY2025 Dec 31, 2023 $825.0K Feb 17, 2026
FY2025 Dec 31, 2022 $16.54M Feb 17, 2026
FY2024 Dec 31, 2021 $7.42M Feb 19, 2025
FY2023 Dec 31, 2020 $7.33M Feb 20, 2024
FY2022 Dec 31, 2019 $13.55M Feb 23, 2023
FY2021 Dec 31, 2018 $4.57M Feb 17, 2022
FY2020 Dec 31, 2017 $7.38M Feb 17, 2021
FY2019 Dec 31, 2016 $6.99M Feb 19, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.22B Feb 17, 2026
FY2025 Dec 31, 2024 $2.22B Feb 17, 2026
FY2024 Dec 31, 2023 $2.05B Feb 19, 2025
FY2023 Dec 31, 2022 $1.98B Feb 20, 2024
FY2022 Dec 31, 2021 $1.88B Feb 23, 2023
FY2019 Dec 31, 2019 $1.48B Feb 19, 2020
FY2019 Dec 31, 2018 $1.69B Feb 19, 2020
FY2018 Dec 31, 2017 $1.73B Feb 20, 2019
FY2017 Dec 31, 2016 $2.02B Feb 21, 2018
FY2016 Sep 30, 2016 $1.99B May 8, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 17, 2026
FY2025 Dec 31, 2024 0 Feb 17, 2026
FY2025 Dec 31, 2023 0 Feb 17, 2026
FY2024 Dec 31, 2022 1 Feb 19, 2025
FY2023 Dec 31, 2021 0 Feb 20, 2024
FY2020 Dec 31, 2020 0 Feb 17, 2021
FY2020 Sep 30, 2020 0 Feb 17, 2021
FY2020 Jun 30, 2020 1 Feb 17, 2021
FY2020 Mar 31, 2020 0 Feb 17, 2021
FY2021 Dec 31, 2019 1 Feb 17, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 17, 2026
FY2025 Dec 31, 2024 0 Feb 17, 2026
FY2025 Dec 31, 2023 0 Feb 17, 2026
FY2024 Dec 31, 2022 1 Feb 19, 2025
FY2023 Dec 31, 2021 0 Feb 20, 2024
FY2020 Dec 31, 2020 0 Feb 17, 2021
FY2020 Sep 30, 2020 0 Feb 17, 2021
FY2020 Jun 30, 2020 1 Feb 17, 2021
FY2020 Mar 31, 2020 0 Feb 17, 2021
FY2021 Dec 31, 2019 1 Feb 17, 2022

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 124.52M Feb 17, 2026
FY2025 Dec 31, 2024 124.08M Feb 17, 2026
FY2024 Dec 31, 2023 123.72M Feb 19, 2025
FY2023 Dec 31, 2022 123.44M Feb 20, 2024
FY2022 Dec 31, 2021 123.08M Feb 23, 2023
FY2021 Dec 31, 2020 123.84M Feb 17, 2022
FY2020 Dec 31, 2019 125.78M Feb 17, 2021
FY2019 Dec 31, 2018 126.22M Feb 19, 2020
FY2018 Dec 31, 2017 142.36M Feb 20, 2019
FY2018 Dec 31, 2016 145.24M Feb 20, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $30.87M Feb 17, 2026
FY2025 Dec 31, 2024 $61.86M Feb 17, 2026
FY2025 Dec 31, 2023 $93.12M Feb 17, 2026
FY2024 Dec 31, 2022 $104.37M Feb 19, 2025
FY2023 Dec 31, 2021 $103.91M Feb 20, 2024
FY2022 Dec 31, 2020 $106.31M Feb 23, 2023
FY2021 Dec 31, 2019 $106.43M Feb 17, 2022